Share on StockTwits

Solazyme (NASDAQ:SZYM) was the target of a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 16,377,706 shares, a growth of 16.5% from the April 30th total of 14,055,815 shares, American Banking News reports. Approximately 30.8% of the company’s shares are sold short. Based on an average trading volume of 1,545,386 shares, the days-to-cover ratio is presently 10.6 days.

In other Solazyme news, CTO Peter Licari sold 7,000 shares of Solazyme stock on the open market in a transaction that occurred on Thursday, May 29th. The stock was sold at an average price of $11.10, for a total value of $77,700.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

SZYM has been the subject of a number of recent research reports. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of Solazyme in a research note on Friday. They now have a $15.00 price target on the stock. Separately, analysts at Credit Suisse cut their price target on shares of Solazyme from $12.00 to $11.00 in a research note on Wednesday, April 2nd. Finally, analysts at Cowen and Company raised their price target on shares of Solazyme from $17.00 to $18.00 in a research note on Tuesday, April 1st. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $14.58.

Shares of Solazyme (NASDAQ:SZYM) opened at 9.99 on Monday. Solazyme has a 52 week low of $8.00 and a 52 week high of $15.00. The stock’s 50-day moving average is $10.21 and its 200-day moving average is $10.64. The company’s market cap is $759.0 million.

Solazyme (NASDAQ:SZYM) last released its earnings data on Monday, May 5th. The company reported ($0.44) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.33) by $0.11. The company had revenue of $12.40 million for the quarter, compared to the consensus estimate of $14.63 million. During the same quarter last year, the company posted ($0.43) earnings per share. Solazyme’s revenue was up 85.1% compared to the same quarter last year. Analysts expect that Solazyme will post $-1.52 EPS for the current fiscal year.

Solazyme, Inc operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.